Dr Stephen Jones has started working at the VU LSC and he will lead a scientific group at the newly established sui generis operational unit of VU LSC, EMBL Partnership Institute.
Stephen’s group will create and research new genome editing tools.
Stephen got his PhD in 2015 in Brown University, Providence, USA. He is coming to LSC from University of Texas, Austin, where he worked very productively in the group of Prof. Ilya Finkelstein researching ageing processes of cells and epigenetic regulation.
Stephen got his works published in the most prestigious scientific publications, such as Cell, PNAS and others. Together with other well-known scientists of this field, such as the Nobel winner J. Doudna, Stephen Jones has established a platform that allows massive parallel kinetic profiling of CRISPR nucleases. The platform is called NucleaSeq and was presented in the Nature Biotechnology in 2020.
‘We expect that the experience of the new group leader and his group would significantly expand our presence in genome editing research areas, contribute towards the development of interdisciplinary research and enhance collaboration between scientists at VU LSC and EMBL. I wish all the best for the new research group. Stephen, welcome to the Life Sciences Center of Vilnius University!’ says Dr Gintaras Valinčius, Director of VU LSC.
More than a week ago, Dr Patrick Pausch and his group started working at the EMBL Partnership Institute of the VU LSC.